[Federal Register Volume 75, Number 110 (Wednesday, June 9, 2010)]
[Notices]
[Page 32798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13821]



[[Page 32798]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

FDA-2010-N-0254


Preparation for International Cooperation on Cosmetic 
Regulations; Public Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing a public 
meeting entitled ``International Cooperation on Cosmetic Regulations 
(ICCR)--Preparation for ICCR-4 Meetings in Toronto, Canada'' to provide 
information and receive comments on the ICCR as well as the upcoming 
meetings in Toronto, Canada. The topics to be discussed are the topics 
for discussion at the forthcoming ICCR Steering Committee meeting. The 
purpose of the meeting is to solicit public input prior to the next 
Steering Committee and expert working group meetings in Toronto, Canada 
the week of July 12, 2010.
    Date and Time: The meeting will be held on Wednesday, July 7, 2010, 
from 1:30 p.m. to 3:30 p.m.
    Location: The meeting will be held in the Washington Theater at the 
Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750 
Rockville Pike, Rockville, MD 20852.
    Contact Person: All participants must register with Jennifer 
Haggerty, Office of the Commissioner, Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 31, rm. 3567, Silver Spring, MD 20903, 
301-796-4600. Register by emailing: [email protected].
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), written material and requests to make oral presentation, 
to the contact person by July 2, 2010.
    If you need special accommodations due to a disability, please 
contact Jennifer Haggerty (see Contact Person) at least 7 days in 
advance.
    Transcripts: Please be advised that as soon as a transcript is 
available, it will be accessible at http://www.regulations.gov. It may 
be viewed at the Division of Dockets Management (HFA-305), Food and 
Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A 
transcript will also be available in either hardcopy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information (HFI-35), Office 
of Management Programs, Food and Drug Administration, 5600 Fishers 
Lane, rm. 6-30, Rockville, MD 20857.

SUPPLEMENTARY INFORMATION: The purpose of the multilateral framework on 
the ICCR is to pave the way for the removal of regulatory obstacles to 
international trade while maintaining global consumer protection.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from the United States, Japan, the European Union, and 
Canada. These regulatory authority members will enter into constructive 
dialogue with their relevant cosmetics' industry trade associations. 
Currently, the ICCR members are Health Canada; the European Directorate 
General for Enterprise and Industry; the Ministry of Health, Labor and 
Welfare of Japan; and the U.S. Food and Drug Administration. All 
decisions made by the consensus will be compatible with the laws, 
policies, rules, regulations, and directives of the respective 
administrations and governments. Members will implement and/or promote 
actions or documents within their own jurisdictions and seek 
convergence of regulatory policies and practices. Successful 
implementation will require input from stakeholders.
    Interested persons may present data, information, or views orally 
or in writing, on issues pending at the public meeting. Time allotted 
for oral presentations may be limited to 10 minutes. Those desiring to 
make oral presentations should notify the contact person by July 2, 
2010, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses, 
telephone number, fax, and e-mail of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    The agenda for the public meeting will be made available on the 
Internet at: http://www.fda.gov/Cosmetics/InternationalActivities/ConferencesMeetingsWorkshops.

    Dated: June 4, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-13821 Filed 6-8-10; 8:45 am]
BILLING CODE 4160-01-S